v3.25.1
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY (Details)
3 Months Ended
Mar. 29, 2025
USD ($)
$ / shares
shares
Equity [Abstract]  
Number of shares, restricted stock | shares 4,833,611
Weighted average grant date fair value, restricted stock granted | $ / shares $ 1.19
Fair Value, restricted stock $ 5,757,391
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $ 6,718,720
Number of shares, restricted stock granted | shares 1,634,864
Weighted average grant date fair value, restricted stock granted | $ / shares $ 1.32
Fair Value, restricted stock granted $ 2,158,020
Sharebased compensation arrangement by sharebased payment award equity instruments other than options aggregate intrinsic value granted
Number of shares, restricted stock Forfeited | shares (150,805)
Weighted average grant date fair value, restricted stock Forfeited | $ / shares $ 1.26
Fair Value, restricted stock Forfeited $ (190,014)
Sharebased compensation arrangement by sharebased payment award equity instruments other than options aggregate intrinsic value forfeited
Number of shares, restricted stock | shares 6,317,670
Weighted average grant date fair value, restricted stock granted | $ / shares $ 1.22
Fair Value, restricted stock $ 7,725,397
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $ 6,002,418
Number of shares, restricted stock Expected to vest | shares 6,317,670